Artes/Anika dermal filler deal
This article was originally published in The Gray Sheet
Executive Summary
Artes Medical, maker of the non-resorbable, FDA-approved injectable dermal filler Artefill, will distribute Anika Therapeutics' FDA-approved hyaluronic acid-based soft-tissue filler Elevess in the U.S. through its 42-rep sales force under an exclusive marketing agreement announced July 8. Because Artefill, which incorporates polymethylmethacrylate microspheres and bovine collagen, requires a skin test and waiting period prior to injection, doctors can use Elevess - which lasts six months - for initial correction during the Artefill skin test waiting period, Artes explains